GB

Gilad Bar-lev

CEO & Board Member at Therapix Biosciences

Mr. Gilad Bar-Lev has served on our Board of Directors since February 2020 and was appointed our Chief Executive Officer On April 22, 2020. From 2012 to 2016, Mr. Bar-Lev served as managing partner of ITCI SPRTN Ltd., a self-owned company specializing in developing and executing investment strategies in publicly traded securities and prior to that, from 2009 to 2012, he served as chief executive officer of Carnie Capital Ltd., a private global investment fund. Mr. Bar-Lev also served as an executive director, serving on the investment committee, of Hada Azrazim Group, a holding company controlling Hadas Arazim Investment House, an Israeli asset management company. Mr. Bar-Lev holds a B.A. degree in economics and finance from Saint Francis College, New York, where he received a Presidential Scholarship and graduated Summa Cum Laude.


Org chart

Sign up to view 2 direct reports

Get started


Teams

This person is not in any teams